Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations

BACKGROUND: Short-term targeted treatment can potentially prevent fall asthma exacerbations while limiting therapy exposure. OBJECTIVE: We sought to compare (1) omalizumab with placebo and (2) omalizumab with an inhaled corticosteroid (ICS) boost with regard to fall exacerbation rates when initiated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Teach, Stephen J., Gill, Michelle A., Togias, Alkis, Sorkness, Christine A., Arbes, Samuel J., Calatroni, Agustin, Wildfire, Jeremy J., Gergen, Peter J., Cohen, Robyn T., Pongracic, Jacqueline A., Kercsmar, Carolyn M., Khurana Hershey, Gurjit K., Gruchalla, Rebecca S., Liu, Andrew H., Zoratti, Edward M., Kattan, Meyer, Grindle, Kristine A., Gern, James E., Busse, William W., Szefler, Stanley J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679705/
https://ncbi.nlm.nih.gov/pubmed/26518090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.09.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados